(Q36855197)

16 August 2017

1 reference

title

Antiflammins: endogenous nonapeptides with regulatory effect on inflammation (English)

1 reference

16 August 2017

Moreno JJ

1

1 reference

16 August 2017

publication date

1 January 1997

1 reference

16 August 2017

1 reference

16 August 2017

volume

28

1 reference

16 August 2017

issue

1

1 reference

16 August 2017

page(s)

23-26

1 reference

Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Lysophosphatidylserine as histamine releaser in mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Antiflammins inhibit synthesis of platelet-activating factor and intradermal inflammatory reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Effects of antiflammins on endotoxin-induced uveitis in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Inhibition of pancreatic phospholipase A2 activity by uteroglobin and antiflammin peptides: possible mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Lipocortin-1: cellular mechanisms and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Anti-phospholipase proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Antiflammin-2 (HDMNKVLDL) does not inhibit phospholipase A2 activities

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Uteroglobin inhibits phospholipase A2 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

In vitro and in vivo effects of the anti-inflammatory peptides, antiflammins

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Effect of nonapeptide fragments of uteroglobin and lipocortin I on oedema and mast cell degranulation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Influence of calcium on arachidonic acid mobilization by murine resident peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Ca2+ influx, phosphoinositide hydrolysis, and histamine release induced by lysophosphatidylserine in mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Effects of an anti-inflammatory peptide (antiflammin 2) on cell influx, eicosanoid biosynthesis and oedema formation by arachidonic acid and tetradecanoyl phorbol dermal application

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

'Antiflammins': two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Uteroglobin: structure, molecular biology, and new perspectives on its function as a phospholipase A2 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Uteroglobin and uteroglobin-like proteins: the uteroglobin family of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Time-course of phospholipase A2, eicosanoid release and cellular accumulation in rat immunological air pouch inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Refinement of the C222(1) crystal form of oxidized uteroglobin at 1.34 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

A novel anti-inflammatory peptide from human lipocortin 5

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Lipocortin-derived peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Prolactin enhances uteroglobin gene expression by uteri of immature rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Inhibition of phagocyte chemotaxis by uteroglobin, an inhibitor of blastocyst rejection.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

Novel peptides derived from a region of local homology between uteroglobin and lipocortin-1 inhibit platelet aggregation and secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900151-6

7 January 2021

10.1016/S0306-3623(96)00151-6

Identifiers

DOI

1 reference

16 August 2017

1 reference